An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Overexpression of IL-6 and its potential negative consequences on the viral immune response.…
Figure 1
Overexpression of IL-6 and its potential negative consequences on the viral immune response. Current scientific evidence supports different scenarios where imbalance on the IL-6 production after viral infection can affect viral clearance, promoting viral persistence and chronic infections. (A) IL-6 might favor Th2 polarization by stimulating STAT3 pathway, and consequently increasing the production of IL-4, and the suppressor of cytokine signaling one protein (SOCS-1). SOCS-1 affects STAT 1 phosphorylation, impairing IFNγ production by decreasing IFNγ self-loop stimulation. (B) IL-6 might impair cytolysis by inducing the production of SOCS-3, affecting phosphorylation of STAT 4, and consequently impairing IFNγ production, an essential IFN type II interferon molecule to promote CD8 and NK cells activation. (C) IL-6 might promote infected cell survival by inducing apoptosis. Overexpression of this cytokine increments Th17 polarization, increasing IL-17 production in the cellular environment. IL-17 pathway induce the production of the anti-apoptotic B-cell lymphoma 2 (Bcl-2) and B-cell lymphoma extra-large (Bcl-xL) proteins, which prevent mitochondrion to produce the cytochrome complex protein (Cyt-c) after stimulation by the pro-apoptotic molecule protease Granzyme B, impairing the production of active apoptotic caspase molecules. An additional scenario includes the production of the programmed death ligand 1 protein (PD-L1) by the concerted action of IFN type I and IL-6. Matching between PD-L1 and programed death protein 1 (PD-1) switches off apoptosis mediated by CD8 T cells.
Angulo J., Martinez-Valdebenito C., Marco C., Galeno H., Villagra E., Vera L., et al. . (2017). Serum levels of interleukin-6 are linked to the severity of the disease caused by Andes Virus. PLoS Negl. Trop. Dis. 11:e0005757. 10.1371/journal.pntd.0005757
-
DOI
-
PMC
-
PubMed
Bardhan K., Anagnostou T., Boussiotis V. A. (2016). The PD1:PD-L1/2 pathway from discovery to clinical implementation. Front. Immunol. 7:550. 10.3389/fimmu.2016.00550
-
DOI
-
PMC
-
PubMed
Beachboard D. C., Horner S. M. (2016). Innate immune evasion strategies of DNA and RNA viruses. Curr. Opin. Microbiol. 32, 113–119. 10.1016/j.mib.2016.05.015
-
DOI
-
PMC
-
PubMed
Borges A. H., O'Connor J. L., Phillips A. N., Ronsholt F. F., Pett S., Vjecha M. J., et al. . (2015). Factors associated with plasma IL-6 levels during HIV infection. J. Infect. Dis. 212, 585–595. 10.1093/infdis/jiv123
-
DOI
-
PMC
-
PubMed
Bouezzedine F., Fardel O., Gripon P. (2015). Interleukin 6 inhibits HBV entry through NTCP down regulation. Virology 481, 34–42. 10.1016/j.virol.2015.02.026
-
DOI
-
PubMed